A brain cancer patient has been left "confused" and "shattered" after learning he took chemotherapy drugs needlessly for more ...

The theory behind leucovorin's use for autism postulates that some children have a blockage in the transport of folic acid ...

Clinical research suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could increase efficacy.

Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests ... Route of Entry for Semliki ...

Window of opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent ...

Zambia and five other low- and middle-income countries will receive free cancer medicines for children through a World Health Organization (WHO) initiative that promises to close the gap in cancer ...

Clinical research by Dana-Farber scientists suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could ...

A potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumour cells in ...

HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a ...

Window of opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent ...